LI
KURA icon

LRI Investments’s Kura Oncology KURA Stock Holding History

LRI Investments’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37K Buy
581
+520
+852% +$4.91K ﹤0.01% 1094
2026
Q1 		$496 Sell
61
-487
-89% -$4.18K ﹤0.01% 1374
2025
Q4 		$5.69K Buy
+548
New +$5.75K ﹤0.01% 1019

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

LRI Investments's KURA Position: Q2 2026 in Review

LRI Investments increased its Kura Oncology (KURA) stake by 852% in Q2 2026, buying an estimated $4.91K and bringing the position to 581 shares worth $6.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

LRI Investments first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • LRI Investments held 581 shares of Kura Oncology worth $6.37K as of Q2 2026.
  • LRI Investments bought 520 Kura Oncology shares in Q2 2026, an estimated $4.91K.
  • Kura Oncology made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1094 holding.
  • LRI Investments first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.